Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- GSK Clinical Trials
GlaxoSmithKline
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gsk Investigational Site
Marseille, France
Noemie Jourde ChicheRecruiting
- Gsk Investigational Site
Rozzano, Milan, Italy
Francesco ReggianiRecruiting
- Gsk Investigational Site
Fukuoka, Japan
Shingo NakayamadaRecruiting
- Recruiting
- Gsk Investigational Site
Charlotte, North Carolina, United States
Gordon LamRecruiting - Gsk Investigational Site
Columbus, Ohio, United States
Isabelle AyoubRecruiting - Gsk Investigational Site
Hixson, Tennessee, United States
Joseph HuffstutterRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Oct 2024
- Primary completion
- 29 Mar 2029
- Completion
- 29 Mar 2029
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 300
- Registry id
- NCT06527872
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.